Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Antimicrobial Reports

Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms

Donà, Daniele MD, PhD*,†; Sharland, Mike MD*; Heath, Paul T. MD*; Folgori, Laura MD*,‡

Author Information
The Pediatric Infectious Disease Journal: August 2019 - Volume 38 - Issue 8 - p 825-827
doi: 10.1097/INF.0000000000002381
  • Buy
  • SDC


Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.